Biocon share price dives 11% after its subsidiary announced deal to acquire Viatris
Shares of biotechnology major Biocon on Monday tanked over 11 per cent after the company said its subsidiary Biocon Biologics has inked a pact to acquire Viatris Inc's biosimilars business.
Biocon share price dives 11% after its subsidiary announced deal to acquire Viatris. Source: Reuters